YIPF5 inhibitors are a class of chemical compounds that specifically target and inhibit the function of YIPF5 (Yip1 domain family member 5), a protein that is integral to the regulation of intracellular membrane trafficking, particularly between the endoplasmic reticulum (ER) and the Golgi apparatus. YIPF5 is part of the YIP (Ypt-interacting protein) family, which plays a critical role in the transport and organization of vesicles within cells. This protein is involved in maintaining the structural integrity of the Golgi and facilitating the proper sorting and delivery of proteins and lipids between cellular organelles. Inhibiting YIPF5 disrupts its normal function in vesicle formation and trafficking, which can lead to a deeper understanding of how membrane-bound compartments communicate and coordinate within the cell.
The design of YIPF5 inhibitors typically involves targeting specific domains of the protein that are essential for its role in vesicular transport. These inhibitors may work by binding to the YIPF5 protein at its active sites, preventing it from interacting with other proteins involved in vesicle formation and cargo transport. The inhibitors likely engage YIPF5 through non-covalent interactions, such as hydrogen bonding, van der Waals forces, or hydrophobic interactions, ensuring a stable and specific blockade of its function. By inhibiting YIPF5, researchers can investigate the mechanisms through which it controls membrane trafficking, organelle morphology, and protein sorting. These inhibitors are valuable tools for studying the broader cellular processes influenced by YIPF5, including the maintenance of the Golgi apparatus and the coordination of ER-to-Golgi transport, providing insights into the fundamental aspects of cellular organization and transport.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Inhibits ADP-ribosylation factor (ARF), indirectly impacting YIPF5 by disrupting Golgi structure. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Ionophore that disrupts Golgi function, indirectly affecting YIPF5-related processes. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Disrupts microtubule polymerization, potentially impacting YIPF5-mediated transport. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
Inhibits actin polymerization, affecting cellular transport and indirectly YIPF5 function. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Inhibits N-linked glycosylation, potentially influencing YIPF5 in the ER-Golgi network. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Disrupts ER calcium storage, indirectly affecting YIPF5 through ER stress pathways. | ||||||
Golgicide A | 1005036-73-6 | sc-215103 sc-215103A | 5 mg 25 mg | $187.00 $670.00 | 11 | |
Directly targets Golgi BFA resistance factor 1, indirectly affecting YIPF5. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor, potentially affecting pathways linked to YIPF5. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor, indirectly affecting YIPF5 through protein synthesis and autophagy pathways. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Lysosomotropic agent, indirectly affecting cellular trafficking pathways involving YIPF5. | ||||||